<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00262600</url>
  </required_header>
  <id_info>
    <org_study_id>1160.26</org_study_id>
    <secondary_id>2005-003894-26</secondary_id>
    <nct_id>NCT00262600</nct_id>
  </id_info>
  <brief_title>Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate</brief_title>
  <official_title>Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <brief_summary>
    <textblock>
      The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran
      etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and
      systemic embolism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Yearly Event Rate for Composite Endpoint of Stroke/SEE</measure>
    <time_frame>36 months</time_frame>
    <description>Time to first occurrence of stroke or systemic embolic event. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Yearly Event Rate for Composite Endpoint of Stroke/SEE/All Cause Death</measure>
    <time_frame>36 months</time_frame>
    <description>Time to first occurrence of stroke, SEE or all cause death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yearly Event Rate: Composite of Stroke/SEE/PE/MI/Vascular Death</measure>
    <time_frame>36 months</time_frame>
    <description>Time to first occurrence of stroke, systemic embolic event, pulmonary embolism, myocardial infarction including silent myocardial infarction or vascular death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding Events (Major and Minor)</measure>
    <time_frame>36 months</time_frame>
    <description>Yearly event rate of bleeds. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25
Major bleeds are adjudicated, whereas minor bleeds are investigator reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Relevant Abnormalities for Intracerebral Hemorrhage and Other Intracranial Hemorrhage (ICH)</measure>
    <time_frame>36 months</time_frame>
    <description>Patients with clinical relevant abnormalities for intracerebral hemorrhage, other intracranial hemorrhage (ICH)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abnormal Liver Function Test</measure>
    <time_frame>36 months</time_frame>
    <description>Number of subjects with abnormal liver function test (LFT), i.e., ALT/AST&gt;3xULN and total bilirubin &gt; 2 x ULN</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">18113</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Dabigatran dose 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>twice a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Warfarin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>once a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dabigatran dose 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>twice a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>warfarin</intervention_name>
    <description>once a day</description>
    <arm_group_label>Warfarin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dabigatran dose 1</intervention_name>
    <description>twice daily</description>
    <arm_group_label>Dabigatran dose 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dabigatran dose 2</intervention_name>
    <description>twice a day</description>
    <arm_group_label>Dabigatran dose 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria Patients with non-valvular atrial fibrillation (AF), at moderate to high
        risk of stroke, or systemic embolism with at least one additional risk factor (i.e.
        previous ischemic stroke, TIA, or systemic embolism, left ventricular dysfunction, age &gt;=75
        years, age &gt;=65 with either diabetes mellitus, history of coronary artery disease or
        hypertension)

        Exclusion criteria

          1. Prosthetic heart valves requiring anticoagulation per se, or hemodynamically relevant
             valve disease that is expected to require surgical intervention during the course of
             the study

          2. Severe, disabling stroke within the previous 6 months, or any stroke within the
             previous 14 days

          3. Conditions associated with an increased risk of bleeding

          4. Contraindication to warfarin treatment

          5. Reversible causes of atrial fibrillation (e.g., cardiac surgery, pulmonary embolism,
             untreated hyperthyroidism).

          6. Plan to perform a pulmonary vein ablation or surgery for cure of the AF

          7. Severe renal impairment (estimated creatinine clearance &lt;=30 mL/min)

          8. Active infective endocarditis

          9. Active liver disease

         10. Women who are pregnant, lactating, or of childbearing potential who refuse to use a
             medically acceptable form of contraception throughout the study

         11. Anaemia (haemoglobin &lt;100g/L) or thrombocytopenia (platelet count &lt;100 x 109/L)

         12. Patients who have developed transaminase elevations upon exposure to ximelagatran

         13. Patients who have received an investigational drug in the past 30 days or are
             participating in another drug study

         14. Patients considered unreliable by the investigator concerning the requirements for
             follow-up during the study and/or compliance with study drug administration, has a
             life expectancy less than the expected duration of the trial due to concomitant
             disease, or has any condition which in the opinion of the investigator, would not
             allow safe participation in the study (e.g., drug addiction, alcohol abuse)

         15. Any known hypersensitivity to galactose if the warfarin used contains galactose.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boehringer Ingelheim</last_name>
    <role>Study Chair</role>
    <affiliation>Boehringer Ingelheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>1160.26.0009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0046 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0057 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0211 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0206 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0115 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lake Havasu City</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0304 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Peoria</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0185 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0305 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0038 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0302 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0121 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0191 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0204 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0213 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0455 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0388 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0441 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0145 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>French Camp</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0333 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0384 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0091 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>LaMesa</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0246 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0345 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Larkspur</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0217 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0059 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0088 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0337 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0326 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mather</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0070 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Merced</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0349 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0087 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0459 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0216 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Redondo Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0135 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0162 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0300 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0371 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0116 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0148 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0270 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0284 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0351 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0043 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0462 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sylmar</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0276 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0379 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0419 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0321 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0449 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0360 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0413 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0362 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0399 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greeley</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0058 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0241 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0278 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0085 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fairfield</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0482 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guilford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0366 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0343 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0382 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0056 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0296 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0429 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0376 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0411 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Deerfield Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0074 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Meyers</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0239 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gainsville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0260 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0265 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0100 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Inverness</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0209 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0033 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0089 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0232 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0240 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0427 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0464 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0259 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0358 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0034 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0199 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0227 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0095 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0037 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0076 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0081 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0111 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0137 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0389 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0417 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0332 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rockledge</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0226 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Safety Harbor</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0385 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0339 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Stuart</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0327 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0271 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0328 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0381 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0159 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0283 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0338 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0319 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0092 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Blue Ridge</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0161 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Conyers</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Couer d'Alene</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0218 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berwyn</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0184 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0233 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0324 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0457 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0237 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0236 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Glenview</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0396 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0438 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0331 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Melrose Park</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0364 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0109 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>North Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0152 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0198 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0433 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winfield</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0041 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0377 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0288 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0436 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0352 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Indinapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jeffersonville</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0235 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0268 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dubuque</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0189 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0357 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0354 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0077 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bowling Green</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0138 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0422 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0178 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0397 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0310 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0144 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0404 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0093 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0340 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>LaCombe</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0391 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0252 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Morgan City</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0132 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Iberia</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0299 Tulane University School Of Medicine</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0048 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shrevport</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0096 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0068 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0114 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0164 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0047 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0079 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0186 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0194 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0255 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bel Air</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0398 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0177 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0073 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0207 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0196 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Takoma Park</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0187 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0052 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Westminster</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0042 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ayer</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0401 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0160 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>East Bridgewater</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0443 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0452 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Natick</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0446 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newtown</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>North Dartmouth</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0470 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Northborough</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0308 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0141 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bloomfield Hills</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0225 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0154 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0171 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0205 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lapeer</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0279 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Muskegon</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0445 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Petoskey</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0274 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rochester Hills</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0165 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0188 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0131 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0421 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0202 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Robbinsondale</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0086 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gulfport</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0119 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0055 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0172 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0257 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0266 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0336 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Charles</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0249 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0128 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Alliance</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0110 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0355 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Papillion</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0346 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0066 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0174 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0430 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0190 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0142 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Browns Mills</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0125 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cherry Hill</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0432 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Elmer</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0448 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0248 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Flemington</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0244 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haddon Heights</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0243 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0478 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oakland</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0392 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ocean</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0472 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paterson</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0221 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0254 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Westwood</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0127 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0423 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0476 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0113 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0281 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0063 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0044 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cortlandt Manor</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0373 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0045 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Garden City</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0251 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kingston</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0229 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0451 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0090 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0183 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Rochelle</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0316 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0146 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>North Massapequa</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0210 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Northport</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0075 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0197 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0320 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0064 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Scarsdale</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0414 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0356 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Watertown</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0039 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0353 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0080 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0412 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0350 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gastonia</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0322 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0173 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0069 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0372 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0094 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0425 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Grand Forks</city>
        <state>North Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0222 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jamestown</city>
        <state>North Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0203 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0434 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Canal Fulton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0083 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0402 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0426 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0479 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0263 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0480 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0267 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0035 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0150 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fairview Park</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0201 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0223 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lorain</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0214 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lyndhurst</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0275 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sandusky</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0103 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Westlake</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0155 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bartlesville</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0435 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0139 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0325 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0078 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hillsboro</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0245 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0133 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0301 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0454 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0295 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0294 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0369 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jenkintown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0303 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jersey Shore</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0431 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0168 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Langhorne</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0293 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Meadowbrook</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newton</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0394 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Norristown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0158 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0181 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0416 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0344 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0466 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0208 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sellersville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0465 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0400 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Upland</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0067 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0212 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pawtucket</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beaufort</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0383 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0313 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0450 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mt. Pleasant</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0166 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Summerville</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0468 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0348 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0084 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0062 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0370 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0323 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0395 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0474 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oak Ridge</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0129 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0410 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0156 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0315 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0444 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0447 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0483 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Killeen</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0335 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0230 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0467 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0269 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0307 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0285 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Marcos</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0215 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0367 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0195 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0453 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0098 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0386 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0428 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fredericksburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0311 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Harrisonburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0292 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0224 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0220 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Salem</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0317 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0287 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0050 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0040 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Burien</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0298 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Olympia</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0250 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0256 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wenatchee</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0193 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0169 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Clarksburg</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0365 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0072 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Elkhorn</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0234 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0099 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0242 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0359 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0461 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0523 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bahía Blanca</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0524 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0533 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0526 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cipolletti</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0529 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coronel Suárez</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0531 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Córdoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0530 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>La Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0527 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mar del Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0532 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mar del Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0525 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quilmes</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0521 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rosario</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0528 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Salta</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0522 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Santa Fe</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0508 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coffs Harbour</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0510 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gosford</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0505 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0506 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Milton</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0509 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ashford</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0507 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Launceston</city>
        <state>Tasmania</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0504 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0501 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0502 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0503 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Prahran</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0543 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0549 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0546 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wels</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0541 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0542 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0544 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0545 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0547 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0548 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0550 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wr. Neustadt</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0564 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0573 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0575 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0572 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brasschaat</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0577 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0571 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0581 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0585 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0586 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0563 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Edegem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0578 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Genk</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0587 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Genk</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0574 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0588 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gilly</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0580 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haine-St.-Paul</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0568 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hasselt</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0569 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kortrijk</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0561 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0579 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0583 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0589 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mol</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0567 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oostende</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0570 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roeselare</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0566 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tienen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0562 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Turnhout</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550648 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Belo Horizonte</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550654 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Blumenau</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550644 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Campinas</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550650 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Curitiba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550651 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Curitiba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550653 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Curitiba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550652 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Goiania</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550645 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Marília</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550646 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>São José do Rio Preto</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550647 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>São José do Rio Preto</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550641 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550642 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550643 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.550649 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Uberaba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0620 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pleven</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0611 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0612 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0613 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0614 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0615 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0616 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0617 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0618 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0622 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0623 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0624 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0625 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0626 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Stara Zagora</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0621 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0694 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0696 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0680 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0712 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0706 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0725 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nanaimo</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0691 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0714 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0701 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Portage la Prairie</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0698 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0707 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bay Roberts</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0676 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Antigonish</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0703 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0679 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ajax</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0677 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0674 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0702 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0720 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0671 Clinical Research &amp; Diagnostic Solutions Inc.</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0692 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Grimsby</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0685 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0697 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0710 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0719 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0721 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0689 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0695 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0708 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0724 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0688 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0672 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0687 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0723 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0715 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0690 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0684 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0718 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0711 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0686 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0693 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Longueuil</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0681 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0683 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0705 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0709 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0716 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0717 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0704 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saint Jerome</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0699 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Charles-Borromee</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0713 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. George-de-Beauce</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0675 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Hyacinthe</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0700 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ste-Foy</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0682 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Terrebonne (Lachenaie)</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0673 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0678 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0771 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0772 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0773 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0774 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0775 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0783 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0784 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0776 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Harbin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0778 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>QingDao</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0781 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0782 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0777 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0780 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shijiazhuang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0801 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0802 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0803 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0815 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0816 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0820 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ostrava 1</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0818 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pardubice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0814 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Plzen-Bory</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0813 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pragha 9</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0811 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Prague 5</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0812 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Praha 6</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0817 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pribram</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0819 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Usti nad Orlici</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0837 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0835 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aarhus C</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0838 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Frederikssund</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0833 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Helsingør</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0834 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Herlev</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0841 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Horsens</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0832 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hvidovre</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0840 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Køge</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0831 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0839 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roskilde</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0836 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Svendborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0856 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Espoo</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0851 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>HUS</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0859 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0855 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0857 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lappeenranta</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0854 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>OYS</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0858 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pori</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0852 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0853 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0875A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>ABBEVILLE cedex</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882B Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882C Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882D Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882E Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882G Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882H Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882I Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882K Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0882L Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0884A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0887A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cholet</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0889A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gap</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0888A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879B Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879C Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879E Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879F Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879G Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879H Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0879S Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880F Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880G Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880J Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0881A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0881D Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joue les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880B Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joué les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880C Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joué les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880D Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joué les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0880E Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Joué les Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0874A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Langres</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0874B Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Langres</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0871A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0873A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>TOULOUSE cedex</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0886A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tourcoing</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0872A Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>VALENCIENNES cedex</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0872C Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Valenciennes cedex</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0872B Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Valenciennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0932 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0948 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0962 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0940 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0936 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0968 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dachau</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0972 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dortmund</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0957 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Duisburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0971 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Erlangen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0965 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Eschweiler</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0934 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0931 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Frankfurt/Main</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0943 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0955 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kassel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0963 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0946 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lahr</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0944 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Limburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0951 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0933 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0945 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0970 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0947 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0952 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0941 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Papenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0959 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Suhl</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0937 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Witten</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0966 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wuppertal</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0908 University Hospital of Alexandroupolis</name>
      <address>
        <city>Alexandroupolis</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0901 General Hospital &quot;Alexandra&quot;, Therapeutic Clinic UOA</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0906 General Hospital &quot;;Evangelismos&quot;</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0907 &quot;Pammakaristos&quot; Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0915 &quot;Hippokratio&quot; Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0914 2nd IKA Hospital, Thessaloniki</name>
      <address>
        <city>Kalamaria-Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0904 General Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0913 University Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0912 General Hospital of Leivadia</name>
      <address>
        <city>Leivadia</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0902 General Hospital &quot; Papageorgiou&quot;</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0910 General Hospital of Thiva</name>
      <address>
        <city>Thiva</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0903 General Hospital of Trikala</name>
      <address>
        <city>Trikala</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.0905 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Voula - Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kowloon</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kowloon</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gyongyos</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Komarom</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pecs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Veszprem</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1056 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1057 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1064 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1065 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1071 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bikaner</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1066 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chennai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1069 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coimbatore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1062 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1058 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Indore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1073 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1067 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kerala</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1068 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kottayam</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1055 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lucknow</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1051 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ludhiana</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1060 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1072 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mysore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1059 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nagpur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1052 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1070 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1110 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1121 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1111 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Be´er Scheva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1117 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Givatayim</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1112 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hadera</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1091 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1113 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1114 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1116 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1118 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1097 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1106 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1119 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1115 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nazareth</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1096 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Petah Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1093 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1094 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1095 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1100 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1103 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Safed</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1092 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel Hashomer</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1098 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel Hashomer</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1109 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1120 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1122 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1099 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zerifin</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1169 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Arezzo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1172 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ascoli Piceno</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1180 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bentivoglio (BO)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1161 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1163 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Castelnuovo Garfagnana</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1178 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chieti</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1171 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Colleferro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1174 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cremona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1167 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Eboli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1168 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Isernia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1162 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Legnago</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1177 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mantova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1165 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Perugia San Sisto</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1175 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1181 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Bonifacio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1173 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Daniele Del Friuli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1170 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sassari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1176 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sassari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1204 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Abeno-ku, Osaka, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1209 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aki-gun, Hiroshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1193 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aoba-ku, Sendai, Miyagi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1211 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chuo-ku, Fukuoka, Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1225 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chuo-ku, Fukuoka, Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1221 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chuo-ku, Kobe, Hyogo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1219 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chuo-ku, Osaka, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1229 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fujioka-shi , Gunma-ken</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1232 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fukushima-shi,Fukushima-ken</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1228 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Higashimatsushimashi, Miyagi-ken</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1208 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Himeji, Hyogo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1214 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Iida, Nagano</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1240 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Isesaki-shi,Gunma</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1224 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Iwakuni, Yamaguchi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1194 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Izumi-ku, Sendai, Miyagi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1241 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kamigyo-ku, Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1220 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kawachinagano, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1203 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kita-ku, Osaka, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1207 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kita-ku, Sakai, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1231 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Komatsu-shi,Ishikawa -ken</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1233 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kyoto-shi,Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1242 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Matsumoto, Nagano</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1210 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minami-ku, Fukuoka, Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1218 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minato, Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1200 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minato-ku, Nagoya, Aichi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1201 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minato-ku, Nagoya, Aichi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1216 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Narashino, Chiba</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1237 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nishinomiya-shi,Hyogo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1223 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Okayama, Okayama</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1197 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oota, Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1212 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Otaru, Hokkaido</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1230 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sagamihara, Kanagawa-ken</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1238 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sapporo-shi,Hokkai-do</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1217 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shibuya, Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1196 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shinjuku, Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1191 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shiroishi-ku, Sapporo, Hokkaido</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1192 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shiroishi-ku, Sapporo, Hokkaido</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1206 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Suita, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1235 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Suita-shi, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1236 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Suita-shi, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1205 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sumiyoshi-ku, Osaka, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1234 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Takatsuki-shi,Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1215 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tokorozawa, Saitama</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1198 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Totsuka-ku, Yokohama, Kanagawa</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1195 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tsuchiura, Ibaragi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1199 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ueda, Nagano</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1222 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wakayama, Wakayama</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1227 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Yanagawa, Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1243 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Yao, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1585 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1586 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chungchungnam-Do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1584 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1591 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1590 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1581 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1582 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1583 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1588 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1589 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1592 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1593 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1297 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kajang,Selangor</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1291 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1292 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1294 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1293 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuching</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1295 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Penang</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1296 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Penang</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1318 Hospital General &quot;Dr. Santiago Ramón y Cajal</name>
      <address>
        <city>Durango</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1311 Hospital Mexico-Americano</name>
      <address>
        <city>Guadalajara</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1317 hOSPITAL bERNARDETTE</name>
      <address>
        <city>Guadalajara</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1312 Hospital de Jesus</name>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1319 Instituto Nacional de Cardiologia</name>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1314 Hospital 1o. de Octubre</name>
      <address>
        <city>México</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1313 Hosp. Angeles Centro Medico del Potosi</name>
      <address>
        <city>San Luis Potosí</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1322 Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</name>
      <address>
        <city>San Luis Potosí</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1344 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Almelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1331 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1336 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Apeldoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1332 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1337 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Den Bosch</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1349 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Den Helder</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1345 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Deventer</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1360 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dirksland</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1348 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dordrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1340 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1358 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1338 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1343 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Goes</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1347 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gorinchem</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1333 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1355 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1361 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Heerlen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1339 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hengelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1346 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hilversum</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1356 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1359 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1341 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Meppel</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1354 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1351 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sneek</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1334 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spiijkenisse</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1335 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Terneuzen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1353 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tiel</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1352 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tilburg</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1350 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Veldhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1342 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Velp</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1357 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Venlo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1396 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gjøvik</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1393 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moss</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1395 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nordbyhagen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1391 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1392 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1397 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1394 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>RUD</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1415 Hospital Alberto Sabogal</name>
      <address>
        <city>Bella Vista</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1411 Clinica San Felipe</name>
      <address>
        <city>Jesús María</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1412 Clínica Anglo Americana</name>
      <address>
        <city>San Isidro</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1413 Hospital Cayetano Heredia</name>
      <address>
        <city>San Martín de Porres</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1414 Clínica Vesalio</name>
      <address>
        <city>Urbanización Sto Tomas de San Borja</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1421 Philippine General Hospital</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1422 Manila Doctors Hospital</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1424 The Medical City</name>
      <address>
        <city>Pasig City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1423 Philippine Heart Center</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1425 St Lukes Medical Center</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1437 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gdynia Redlowo</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1436 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gdynia</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1438 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gdynia</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1435 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1439 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1440 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1433 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pulawy</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1431 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1432 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1434 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zabrze</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1456 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Amadora</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1451 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Carnaxide</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1454 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coimbra</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1459 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coimbra</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1457 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Covilhã</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1453 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1458 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1455 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1452 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Setúbal</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1471 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1472 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1478 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cluj Napoca</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1501 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1502 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1503 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1504 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1505 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1506 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1507 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1508 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1509 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1510 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1511 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1512 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1513 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1514 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1515 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1531 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1532 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1548 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Banska Bystrica</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1541 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1542 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1543 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1544 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1545 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1546 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1549 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kosice</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1550 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kosice</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1547 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zilina</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1562 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bloemfontein</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1569 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Boksburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1561 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1564 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1567 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1568 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1566 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1563 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Randburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1565 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Somerset West</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1601 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1606 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cadiz</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1607 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fuenlabrada (Madrid)</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1604 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leganés, Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1609 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Madrid-San Lorenzo del Escorial</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1603 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1608 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1605 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Móstoles (Madrid)</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1602 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1633 Sahlgrenska Sjukhuset</name>
      <address>
        <city>Göteboerg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1629 AVK-mott, Spec.M1, Länssjukhuset Ryhov</name>
      <address>
        <city>Jönköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1631 Universitetssjukhuset i Linköping</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1627 Hjärtmott. ING 35, Malmö Universitetssjukhus MAS</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1625 Hjärtmott./Medicinkliniken, Vrinnevisjukhuset</name>
      <address>
        <city>Norrköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1628 Rådhusg. 29, Lars Mörlids Läkarmottagning</name>
      <address>
        <city>Nässjö</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1626 Hjärtkärllaboratoriet, Danderyds Sjukhus AB</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1632 Capio S:t Görans Sjukhus</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1634 Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1624 Klin. forskningscentrum, Norrlands Universitetssjukhus</name>
      <address>
        <city>Umeå</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1621 Kardiologiska kliniken, Akademiska Sjukhuset</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1635 UCR/Uppsala</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1622 Hjärtmottagningen, Centrallasarettet</name>
      <address>
        <city>Västerås</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1623 Kardiologiska kliniken, Universitetssjukhuset</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1652 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1655 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bellinzona</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1651 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1654 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lugano</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1680 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Changhua County</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1683 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hualien</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1682 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1679 China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1681 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1671 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1672 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1673 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1674 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1675 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1676 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1677 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1678 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taoyuan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1701 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1702 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1703 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chiangmai</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1704 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Khon Kaen</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1705 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Muang Nakhonratchasima</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1715 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Adana</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1711 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1713 Gazi Universitesi Tip Fakultesi Kardiyoloji Abd</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1714 Dokuz Eylul Universitesi Tip Fakultesi</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1727 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dnyepropetrovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1726 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1724 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1725 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1721 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1722 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1723 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1728 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1730 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1731 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1729 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lvov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1744 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1746 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chertsey</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1747 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1750 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Harrow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1753 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hull</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1755 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kirkcaldy, Fife</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1749 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Londonderry</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1741 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1756 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1742 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1751 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newport</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1752 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Northampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1745 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Portadown, County Atrim</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1743 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Romford, Essex</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1754 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Stoke-On-Trent</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1160.26.1748 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>York</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Peru</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2005</study_first_submitted>
  <study_first_submitted_qc>December 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2005</study_first_posted>
  <results_first_submitted>November 18, 2010</results_first_submitted>
  <results_first_submitted_qc>January 17, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 10, 2011</results_first_posted>
  <last_update_submitted>November 5, 2014</last_update_submitted>
  <last_update_submitted_qc>November 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2014</last_update_posted>
  <responsible_party>
    <name_title>Boehringer Ingelheim, Study Chair</name_title>
    <organization>Boehringer Ingelheim</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
    <mesh_term>Dabigatran</mesh_term>
    <mesh_term>Anticoagulants</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dabigatran 110 mg</title>
          <description>110 mg twice daily, total daily dose 220 mg</description>
        </group>
        <group group_id="P2">
          <title>Dabigatran 150 mg</title>
          <description>150 mg twice daily, total daily dose 300 mg</description>
        </group>
        <group group_id="P3">
          <title>Warfarin</title>
          <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6015"/>
                <participants group_id="P2" count="6076"/>
                <participants group_id="P3" count="6022"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5780"/>
                <participants group_id="P2" count="5824"/>
                <participants group_id="P3" count="5756"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="235"/>
                <participants group_id="P2" count="252"/>
                <participants group_id="P3" count="266"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="41"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="128"/>
                <participants group_id="P2" count="145"/>
                <participants group_id="P3" count="139"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not Treated</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="24"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not Specified</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="59"/>
                <participants group_id="P3" count="62"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dabigatran 110 mg</title>
          <description>110 mg twice daily, total daily dose 220 mg</description>
        </group>
        <group group_id="B2">
          <title>Dabigatran 150 mg</title>
          <description>150 mg twice daily, total daily dose 300 mg</description>
        </group>
        <group group_id="B3">
          <title>Warfarin</title>
          <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6015"/>
            <count group_id="B2" value="6076"/>
            <count group_id="B3" value="6022"/>
            <count group_id="B4" value="18113"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71.4" spread="8.6"/>
                    <measurement group_id="B2" value="71.5" spread="8.8"/>
                    <measurement group_id="B3" value="71.6" spread="8.6"/>
                    <measurement group_id="B4" value="71.5" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;65</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="998"/>
                    <measurement group_id="B2" value="1030"/>
                    <measurement group_id="B3" value="953"/>
                    <measurement group_id="B4" value="2981"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>65&lt;= and &lt;75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2668"/>
                    <measurement group_id="B2" value="2580"/>
                    <measurement group_id="B3" value="2646"/>
                    <measurement group_id="B4" value="7894"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2349"/>
                    <measurement group_id="B2" value="2466"/>
                    <measurement group_id="B3" value="2423"/>
                    <measurement group_id="B4" value="7238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3865"/>
                    <measurement group_id="B2" value="3840"/>
                    <measurement group_id="B3" value="3809"/>
                    <measurement group_id="B4" value="11514"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2149"/>
                    <measurement group_id="B2" value="2236"/>
                    <measurement group_id="B3" value="2213"/>
                    <measurement group_id="B4" value="6598"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5593"/>
                    <measurement group_id="B2" value="5660"/>
                    <measurement group_id="B3" value="5615"/>
                    <measurement group_id="B4" value="16868"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="421"/>
                    <measurement group_id="B2" value="416"/>
                    <measurement group_id="B3" value="407"/>
                    <measurement group_id="B4" value="1244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4208"/>
                    <measurement group_id="B2" value="4268"/>
                    <measurement group_id="B3" value="4203"/>
                    <measurement group_id="B4" value="12679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="67"/>
                    <measurement group_id="B4" value="176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="955"/>
                    <measurement group_id="B2" value="965"/>
                    <measurement group_id="B3" value="955"/>
                    <measurement group_id="B4" value="2875"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="799"/>
                    <measurement group_id="B2" value="786"/>
                    <measurement group_id="B3" value="797"/>
                    <measurement group_id="B4" value="2382"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>USA, Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2166"/>
                    <measurement group_id="B2" value="2200"/>
                    <measurement group_id="B3" value="2167"/>
                    <measurement group_id="B4" value="6533"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Central Europe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="707"/>
                    <measurement group_id="B2" value="706"/>
                    <measurement group_id="B3" value="706"/>
                    <measurement group_id="B4" value="2119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Western Europe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1544"/>
                    <measurement group_id="B2" value="1555"/>
                    <measurement group_id="B3" value="1552"/>
                    <measurement group_id="B4" value="4651"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Latin America</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="320"/>
                    <measurement group_id="B2" value="320"/>
                    <measurement group_id="B3" value="316"/>
                    <measurement group_id="B4" value="956"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="923"/>
                    <measurement group_id="B2" value="933"/>
                    <measurement group_id="B3" value="926"/>
                    <measurement group_id="B4" value="2782"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="355"/>
                    <measurement group_id="B2" value="362"/>
                    <measurement group_id="B3" value="355"/>
                    <measurement group_id="B4" value="1072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking history</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Non-smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2941"/>
                    <measurement group_id="B2" value="2993"/>
                    <measurement group_id="B3" value="3006"/>
                    <measurement group_id="B4" value="8940"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="440"/>
                    <measurement group_id="B2" value="447"/>
                    <measurement group_id="B3" value="448"/>
                    <measurement group_id="B4" value="1335"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ex-smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2633"/>
                    <measurement group_id="B2" value="2636"/>
                    <measurement group_id="B3" value="2567"/>
                    <measurement group_id="B4" value="7836"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Regular Alcohol Consumption</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4017"/>
                    <measurement group_id="B2" value="4077"/>
                    <measurement group_id="B3" value="4040"/>
                    <measurement group_id="B4" value="12134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1996"/>
                    <measurement group_id="B2" value="1999"/>
                    <measurement group_id="B3" value="1981"/>
                    <measurement group_id="B4" value="5976"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Yearly Event Rate for Composite Endpoint of Stroke/SEE</title>
        <description>Time to first occurrence of stroke or systemic embolic event. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
        <time_frame>36 months</time_frame>
        <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran 110 mg</title>
            <description>110 mg twice daily, total daily dose 220 mg</description>
          </group>
          <group group_id="O2">
            <title>Dabigatran 150 mg</title>
            <description>150 mg twice daily, total daily dose 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Warfarin</title>
            <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
          </group>
        </group_list>
        <measure>
          <title>Yearly Event Rate for Composite Endpoint of Stroke/SEE</title>
          <description>Time to first occurrence of stroke or systemic embolic event. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
          <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
          <units>yearly event rate (percentage)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6015"/>
                <count group_id="O2" value="6076"/>
                <count group_id="O3" value="6022"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54"/>
                    <measurement group_id="O2" value="1.11"/>
                    <measurement group_id="O3" value="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority comparison of dabigatran 110 mg to warfarin</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Comparisons between treatment groups were performed using a Cox regression analysis with treatment in the model.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>p-value for protocol specified margin of 1.46</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority comparison of dabigatran 150 mg to warfarin</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Comparisons between treatment groups were performed using a Cox regression analysis with treatment in the model.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>p-value for protocol specified margin of 1.46</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.65</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.52</ci_lower_limit>
            <ci_upper_limit>0.81</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Yearly Event Rate for Composite Endpoint of Stroke/SEE/All Cause Death</title>
        <description>Time to first occurrence of stroke, SEE or all cause death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
        <time_frame>36 months</time_frame>
        <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran 110 mg</title>
            <description>110 mg twice daily, total daily dose 220 mg</description>
          </group>
          <group group_id="O2">
            <title>Dabigatran 150 mg</title>
            <description>150 mg twice daily, total daily dose 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Warfarin</title>
            <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
          </group>
        </group_list>
        <measure>
          <title>Yearly Event Rate for Composite Endpoint of Stroke/SEE/All Cause Death</title>
          <description>Time to first occurrence of stroke, SEE or all cause death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
          <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
          <units>yearly event rate (percentage)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6015"/>
                <count group_id="O2" value="6076"/>
                <count group_id="O3" value="6022"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.85"/>
                    <measurement group_id="O2" value="4.32"/>
                    <measurement group_id="O3" value="5.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2206</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using a Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>1.04</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0015</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using a Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.83</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>0.93</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Yearly Event Rate: Composite of Stroke/SEE/PE/MI/Vascular Death</title>
        <description>Time to first occurrence of stroke, systemic embolic event, pulmonary embolism, myocardial infarction including silent myocardial infarction or vascular death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
        <time_frame>36 months</time_frame>
        <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran 110 mg</title>
            <description>110 mg twice daily, total daily dose 220 mg</description>
          </group>
          <group group_id="O2">
            <title>Dabigatran 150 mg</title>
            <description>150 mg twice daily, total daily dose 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Warfarin</title>
            <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
          </group>
        </group_list>
        <measure>
          <title>Yearly Event Rate: Composite of Stroke/SEE/PE/MI/Vascular Death</title>
          <description>Time to first occurrence of stroke, systemic embolic event, pulmonary embolism, myocardial infarction including silent myocardial infarction or vascular death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25</description>
          <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
          <units>yearly event rate (percentage)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6015"/>
                <count group_id="O2" value="6076"/>
                <count group_id="O3" value="6022"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.26"/>
                    <measurement group_id="O2" value="3.68"/>
                    <measurement group_id="O3" value="4.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.7508</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using a Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.11</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0093</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using a Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bleeding Events (Major and Minor)</title>
        <description>Yearly event rate of bleeds. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25
Major bleeds are adjudicated, whereas minor bleeds are investigator reported.</description>
        <time_frame>36 months</time_frame>
        <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran 110 mg</title>
            <description>110 mg twice daily, total daily dose 220 mg</description>
          </group>
          <group group_id="O2">
            <title>Dabigatran 150 mg</title>
            <description>150 mg twice daily, total daily dose 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Warfarin</title>
            <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
          </group>
        </group_list>
        <measure>
          <title>Bleeding Events (Major and Minor)</title>
          <description>Yearly event rate of bleeds. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25
Major bleeds are adjudicated, whereas minor bleeds are investigator reported.</description>
          <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
          <units>yearly event rate (percentage)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6015"/>
                <count group_id="O2" value="6076"/>
                <count group_id="O3" value="6022"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Major bleeds</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.99"/>
                    <measurement group_id="O2" value="3.55"/>
                    <measurement group_id="O3" value="3.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor bleeds</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.16"/>
                    <measurement group_id="O2" value="14.85"/>
                    <measurement group_id="O3" value="16.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis is for adjudicated major bleeds</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0026</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.70</ci_lower_limit>
            <ci_upper_limit>0.93</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis is for adjudicated major bleeds</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3146</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Relevant Abnormalities for Intracerebral Hemorrhage and Other Intracranial Hemorrhage (ICH)</title>
        <description>Patients with clinical relevant abnormalities for intracerebral hemorrhage, other intracranial hemorrhage (ICH)</description>
        <time_frame>36 months</time_frame>
        <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran 110 mg</title>
            <description>110 mg twice daily, total daily dose 220 mg</description>
          </group>
          <group group_id="O2">
            <title>Dabigatran 150 mg</title>
            <description>150 mg twice daily, total daily dose 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Warfarin</title>
            <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Relevant Abnormalities for Intracerebral Hemorrhage and Other Intracranial Hemorrhage (ICH)</title>
          <description>Patients with clinical relevant abnormalities for intracerebral hemorrhage, other intracranial hemorrhage (ICH)</description>
          <population>Randomized set - The randomized set includes all randomized subjects in the treatment groups to which they were randomized, regardless of whether the subjects took randomized study medication or not.</population>
          <units>yearly event rate (percentage)]</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5983"/>
                <count group_id="O2" value="6059"/>
                <count group_id="O3" value="5998"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>intracerebral hemorrhage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12"/>
                    <measurement group_id="O2" value="0.10"/>
                    <measurement group_id="O3" value="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>intracranial hemorrhage (ICH)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23"/>
                    <measurement group_id="O2" value="0.32"/>
                    <measurement group_id="O3" value="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis of ICH</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.30</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.19</ci_lower_limit>
            <ci_upper_limit>0.45</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis of ICH</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>p-value is for superiority testing</p_value_desc>
            <method>Regression, Cox</method>
            <method_desc>Comparisons between treatment groups were performed using Cox regression analysis with treatment in the model.</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.41</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.28</ci_lower_limit>
            <ci_upper_limit>0.60</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Abnormal Liver Function Test</title>
        <description>Number of subjects with abnormal liver function test (LFT), i.e., ALT/AST&gt;3xULN and total bilirubin &gt; 2 x ULN</description>
        <time_frame>36 months</time_frame>
        <population>Safety set - all subjects who were randomized and received at least 1 dose of study drug</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran 110 mg</title>
            <description>110 mg twice daily, total daily dose 220 mg</description>
          </group>
          <group group_id="O2">
            <title>Dabigatran 150 mg</title>
            <description>150 mg twice daily, total daily dose 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Warfarin</title>
            <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
          </group>
        </group_list>
        <measure>
          <title>Abnormal Liver Function Test</title>
          <description>Number of subjects with abnormal liver function test (LFT), i.e., ALT/AST&gt;3xULN and total bilirubin &gt; 2 x ULN</description>
          <population>Safety set - all subjects who were randomized and received at least 1 dose of study drug</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5983"/>
                <count group_id="O2" value="6059"/>
                <count group_id="O3" value="5998"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>36 months</time_frame>
      <desc>Number of participants at risk represents the number of participants who received study medication. The following number of subjects did not take any study drug after randomization: 32 assigned to Dabigatran 110 mg; 17 assigned to Dabigatran 150 mg; and 24 assigned to Warfarin.</desc>
      <group_list>
        <group group_id="E1">
          <title>Dabigatran 110 mg</title>
          <description>110 mg twice daily, total daily dose 220 mg</description>
        </group>
        <group group_id="E2">
          <title>Dabigatran 150 mg</title>
          <description>150 mg twice daily, total daily dose 300 mg</description>
        </group>
        <group group_id="E3">
          <title>Warfarin</title>
          <description>Target International Normalized Ratio (INR) of 2.0 to 3.0</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1263" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1289" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1357" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Heparin-induced thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypereosinophilic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypocoagulable state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy mediastinal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lymphatic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sideroblastic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Splenic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spontaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic valve calcification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic valve sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="74" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="65" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="83" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="58" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="73" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Conduction disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coronary artery perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coronary artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Electromechanical dissociation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mitral valve prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mitral valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nodal rhythm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pericarditis constrictive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prinzmetal angina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Restrictive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sinus arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Torsade de pointes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventricular hypokinesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Congenital arterial malformation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diverticulitis Meckel's</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Exomphalos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal arteriovenous malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventricular septal defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>External ear pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Addison's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Inappropriate antidiuretic hormone secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thyrotoxic crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis fugax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blindness transient</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Conjunctival discolouration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dacryostenosis acquired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyphaema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypotony of eye</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Necrotising retinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Optic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pseudophakia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Retinal tear</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Retinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal tenderness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Alcoholic pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anal polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Appendiceal mucocoele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coeliac disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colonic obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colonic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Duodenitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dyskinesia oesophageal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Enterocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Enterovesical fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="41" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhagic erosive gastritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hernial eventration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hiatus hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intussusception</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Large intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malabsorption</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Melanosis coli</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mouth haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal spasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oral discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatic insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Paraesthesia oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Periodontal disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peritoneal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pharyngoesophageal diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Presbyoesophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectal lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Salivary gland cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Stress ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adhesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="46" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Condition aggravated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hernia obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Implant site inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Injection site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ischaemic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mechanical complication of implant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mucosal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pelvic mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biliary dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cytolytic hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatotoxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Primary amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abscess intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Alpha haemolytic streptococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Appendiceal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biliary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bursitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Catheter sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cellulitis of male external genital organ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cervicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Creutzfeldt-Jakob disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Disseminated tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Enterococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Enterococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Epiglottitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Escherichia bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eye infection viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Helminthic infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Herpes zoster ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Histoplasmosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Implant site cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Incision site cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Infected cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Infusion site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Jejunal gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Keratitis herpetic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Meningitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Meningitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteomyelitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteomyelitis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pelvic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pelvic infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peridiverticular abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Periorbital abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peritoneal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peritonsillar abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pharyngeal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumocystis jiroveci pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="74" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="70" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="62" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumonia primary atypical</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Postoperative abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Proteus infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Psoas abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pyonephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pyothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Salmonella bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Staphylococcal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subacute endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Superinfection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tinea pedis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Toxoplasmosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>West Nile viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental exposure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Adrenal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Agitation postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anastomotic complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Back injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Brain herniation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Burns third degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker malfunction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cataract operation complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Collapse of lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Complication of device insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Confusion postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Device breakage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Device electrical finding</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Device lead damage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Drug administration error</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Drug toxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eye injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Failure to capture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="43" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Flail chest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastroenteritis radiation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Graft complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Heart injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Heat exhaustion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Iatrogenic injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>In-stent coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Joint sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Laryngeal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Limb crushing injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Multiple drug overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Narcotic intoxication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nerve root injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pacemaker complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatic injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pocket erosion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post concussion syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post procedural fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pubic rami fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Respiratory fume inhalation disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Retinal scar</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Scrotal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Splenic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Splenic injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sternal fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subcutaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Therapeutic agent toxicity</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thrombosis in device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Transfusion reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Transurethral resection syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Traumatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Underdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vaccination complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vascular bypass dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ventriculoperitoneal shunt malfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vertebral injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anticoagulation drug level above therapeutic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biopsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biopsy breast</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biopsy endometrium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biopsy lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Biopsy prostate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood albumin decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood calcium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood osmolarity decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood pressure decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood uric acid increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Brain natriuretic peptide increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Carbohydrate antigen 125 increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac electrophysiologic study</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac stress test</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac stress test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coagulation factor increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coagulation test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coagulation time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colonoscopy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colonoscopy abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Creatinine renal clearance decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Echocardiogram abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Electroencephalogram abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haematocrit decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intraocular pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lymphocyte count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Megakaryocytes decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Occult blood positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophagogastroduodenoscopy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Precancerous cells present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prothrombin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sinus rhythm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tumour marker increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Venous pressure jugular increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypochloraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ketosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Starvation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tetany</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthritis reactive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Articular disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic amyotrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Jaw cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Joint range of motion decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Loose body in joint</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Monarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Muscle tightness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nodule on extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pseudarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sacroiliitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Shoulder deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vertebral column mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Abdominal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acoustic neuroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>B-cell small lymphocytic lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Benign bone neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bone cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bone neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Brain cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac fibroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac neoplasm unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Central nervous system leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Choroid melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon cancer stage 0</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colorectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ependymoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer non-resectable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastric neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stromal tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tract adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Head and neck cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypopharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Inflammatory carcinoma of the breast</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Inflammatory myofibroblastic tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Langerhans' cell granulomatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Large cell carcinoma of the respiratory tract stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer stage 0</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Laryngeal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leukaemia monocytic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Liposarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage III</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lymphocytic lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malignant melanoma stage III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of renal pelvis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malignant palate neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malignant peritoneal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mantle cell lymphoma recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to eye</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to kidney</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to pleura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to spleen</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastases to the mediastinum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastatic carcinoid tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastatic gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neoplasm prostate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma of the skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neuroendocrine tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oesophageal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oncologic complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oropharyngeal cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ovarian adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ovarian neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Paraneoplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Penis carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peritoneal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Phaeochromocytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Plasmacytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Seborrhoeic keratosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Small cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Superficial spreading melanoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>T-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Testicular cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Throat cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tonsil cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tumour flare</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tumour invasion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urethral cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urethral papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urinary bladder adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Amyotrophic lateral sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anoxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Basilar artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Burning sensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Carotid arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Carotid artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebellar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral circulatory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral hypoperfusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cerebrovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Complex partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Frontotemporal dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Global amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Grand mal convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypoxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Monoparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Narcolepsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neurological decompensation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Parkinsonism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peripheral paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post herpetic neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post-traumatic headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Posterior interosseous syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pseudoparalysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Radial nerve palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Radicular syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subdural hygroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="34" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Unresponsive to stimuli</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Visual field defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wernicke's encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Apathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bereavement reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Delusional disorder, unspecified type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Drug abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hallucination, auditory</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mania</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Somatisation disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Somatoform disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder neck obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder tamponade</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhage urinary tract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nephrosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pelvi-ureteric obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urethral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urethral obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colpocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ovarian mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pelvic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatic obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Scrotal haematocoele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Uterine enlargement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vaginal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vaginal polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute interstitial pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Allergic cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Alveolitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchial secretion retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diaphragmatic rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="45" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eosinophilic pneumonia acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Idiopathic pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mediastinal mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nasal turbinate hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nocturnal dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pharyngeal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pickwickian syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumomediastinum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Postnasal drip</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary alveolar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pulmonary toxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Respiratory disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Restrictive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sinus disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Status asthmaticus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wegener's granulomatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Campbell de Morgan spots</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic bullosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Diabetic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eczema nummular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Erythema multiforme</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Henoch-Schonlein purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leukocytoclastic vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pemphigus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Photosensitivity allergic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Photosensitivity reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subcutaneous emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Joint prosthesis user</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Refusal of treatment by patient</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Walking disability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Alcohol rehabilitation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm repair</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic valve repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic valve replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthrodesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Artificial urinary sphincter implant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bladder operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac ablation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker battery replacement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker revision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Chemotherapy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Colon operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Contraceptive diaphragm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coronary angioplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Coronary artery bypass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Craniotomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Debridement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Endarterectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eventration procedure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Explorative laparotomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Eye operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gamma radiation therapy to prostate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tube insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Heart valve operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hepatectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hernia repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>High frequency ablation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hysterosalpingo-oophorectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Incisional hernia repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Internal fixation of fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Laparoscopic surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Malignant tumour excision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mass excision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mastectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Medical device implantation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Medical device removal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mitral valve repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Mitral valve replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Nerve block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Open reduction of fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Osteosynthesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Patellectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Pleurodesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Polymedication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Prostatic operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Radiotherapy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Resuscitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Shoulder arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Skin neoplasm excision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Small intestinal resection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Spinal laminectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Stent placement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Sternotomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Surgery</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Tendon operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thoracotomy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thyroidectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Toe amputation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Transfusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Transurethral prostatectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Umbilical hernia repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Uterine dilation and curettage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wound drainage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic calcification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Aortic thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arterial stenosis limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis obliterans</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Exsanguination</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Femoral arterial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Iliac artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Jugular vein distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Lymphangiectasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Phlebitis deep</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subclavian artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Varicose vein ruptured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vascular occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Venous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Venous insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Wound haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2286" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="2273" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="2118" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="347" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="360" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="308" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="362" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="344" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="83" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="258" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="310" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="296" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="367" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="361" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="341" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="436" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="439" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="440" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="315" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="309" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="327" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="281" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="272" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="322" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="246" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="306" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="318" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="442" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="440" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="536" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="318" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="308" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="343" subjects_at_risk="5998"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="460" subjects_at_risk="5983"/>
                <counts group_id="E2" subjects_affected="483" subjects_at_risk="6059"/>
                <counts group_id="E3" subjects_affected="506" subjects_at_risk="5998"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Boehringer Ingelheim Call Center</name_or_title>
      <organization>Boehringer Ingelheim Pharmaceuticals</organization>
      <phone>1-800-243-0127</phone>
      <email>clintriage.rdg@boehringer-ingelheim.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

